Poly(ethylene carbonate) microspheres: Manufacturing process and internal structure characterization

Journal of Controlled Release

Volumn 67, Issue 1, 2000, Pages 89-99

  Lambert, Olivier ^a   Nagele, Oscar ^a   Loux, Veronique ^a   Bonny, Jean Daniel ^a   Marchal Heussler, Laurent ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Aseptic manufacturing process; GM CSF; Microspheres; Multiple emulsion; Poly(ethylene carbonate)

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MICROSPHERE; POLY(ETHYLENE CARBONATE); POLYETHYLENE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG MANUFACTURE; DRUG RELEASE; ENCAPSULATION; IN VITRO STUDY; MOLECULAR WEIGHT; PARTICLE SIZE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCANNING ELECTRON MICROSCOPY; SURFACE TENSION; VISCOSITY;

CELL DIVISION; CELL LINE; DRUG COMPOUNDING; DRUG STABILITY; EMULSIONS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MICROSPHERES; MOLECULAR WEIGHT; PARTICLE SIZE; POLYETHYLENES; SOLUTIONS; SURFACE TENSION; VISCOSITY;

EID: 0034659632     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(00)00198-X     Document Type: Article

References (29)

1. Bodmeier R., Chen H., Davidson R.G., Hardee G.E. Microencapsulation of antimicrobial ceftior drugs. Pharm. Dev. Technol. 2:(4):1997;323-334.
2. Bodmeier R., Wang J., Bhagwatwar H. Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. II. w/o/w multiple emulsion technique for water-soluble drugs. J. Microencapsul. 9:(1):1992;99-107.
3. Blanco-Pietro M.J., Fattal E., Gulik A., Dedieu J.C., Roques B.P., Couvreur P. Characterization and morphological analysis of a cholecystokinin derivative peptide-loaded poly(lactide-co-glycolide) microspheres prepared by a water-in-oil-in-water emulsion solvent evaporation method. J. Control. Rel. 43:1997;81-87.
4. Morlock M., Kissel T., Li Y.X., Koll H., Winter G. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. J. Control. Rel. 56:1998;105-115.
5. Sah H., Toddywala R., Chien Y.W. Continuous release of proteins from biodegradable microcapsules and in vivo evaluation of their potential as a vaccine adjuvant. J. Control. Rel. 35:1995;137-144.
6. Leo E., Pecquet S., Rojas J., Couvreur P., Fattal E. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycoside) microspheres prepared by a w/o/w solvent evaporation method. J. Microencapsul. 15:(4):1998;421-430.
7. Rojas J., Pinto-Alphandary H., Leo E., Pecquet S., Couvreur P., Gulik A., Fattal E. A polysorbate-base non-ionic surfactant can modulate loading and release of beta-Lactoglobulin entrapped in multiphase poly(DL-lactide-co-glycolide) microspheres. Pharm. Res. 16:(2):1999;255-260.
8. Jeffery H., Davis S.S., O'Hagan D.T. The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil-in-water) emulsion solvent evaporation technique. Pharm. Res. 10:1993;362-368.
9. Gabor F., Ertl B., Wirth M., Mallinger R. Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics. J. Microencapsul. 16:(1):1999;1-12.
10. Heller J., Baker R.W. Theory and practice of controlled drug delivery from bioerodible polymers. Baker R.W. Controlled Release of Bioactive Materials. 1980;1-17 Academic Press, New York.
11. Heller J. Use of polymer in controlled release of bioactive agents. Robinson J.R., Lee V.H. Controlled Drug Delivery. 1987;204-207 Marcel Dekker, New York and Basel.
12. Johnson R.E., Lanaski L.A., Gupta V., Griffin M.J., Gaud H.T., Needham T.E., Zia H. Stability of atriopeptin III in poly(D,L-lactide-co-glycolide) microspheres. J. Control. Rel. 17:1991;61-68.
13. Sparer R.V., Shih C., Ringeisen C.D., Himmelstein K.J. Controlled release from bioerodible poly(orthoesters) drug delivery systems. J. Control. Rel. 1:1984;23-32.
14. M. Acemoglu, S. Bantle, D. Bodmer, S. Cammisuli, P. Hiestand, F. Nimmerfall, G. Stoll, Polymeric Matrices and their uses in Pharmaceutical compositions, EP 94/02833, March 2, 1995.
15. Acemoglu M., Nimmerfall F., Bantle S., Stoll G.H. Poly(ethylene carbonate)s. Part I: Syntheses and structural effects on biodegradation. J. Control. Rel. 49:1997;263-276.
16. Heller W. Treatment of viscosity data on polymer solutions (an analysis of equations and procedures). I. Intrinsic viscosity and limiting slopes constants. J. Colloid. Interf. Sci. 9:1954;547-556.
17. Alex R., Bodmeier R. Encapsulation of water soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. J. Microencapsul. 7:(3):1990;347-355.
18. Uchida T., Yoshida K., Goto S. Preparation and characterization of polylatic acid microspheres containing water-soluble dyes using a novel w/o/w emulsion solvent evaporation method. J. Microencapsul. 13:(2):1996;219-228.
19. Morlock M., Koll H., Winter G., Kissel T. Microencapsulation of rh-erythropoietin using poly(D,L-lactide-co-glycolide): Protein stability and effects of stabilizing excipients. Eur. J. Pharm. Biopharm. 43:1997;29-36.
20. 2 emulsion solvent evaporation method. Int. J. Pharm. 111:1994;137-145.
21. Ogawa Y., Yamamoto M., Okada H., Yashiki T., Shimamoto T. A new technique to efficiency entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. Chem. Pharm. Bull. 36:(3):1988;1095-1103.
22. Huatan H., Collett J.H., Attwood D. The microencapsulation of protein using a novel ternary blend based on poly(ε-caprolactone). J. Microencapsul. 12:(5):1995;557-567.
23. Bodmeier R., Chen H., Tyle P., Jarosz P. Pseudoephedrine HCl microspheres formulated into an oral suspension dosage form. J. Control. Rel. 15:1991;65-77.
24. Rafati H., Coombes A.G.A., Adler J., Holland J., Davis S.S. Protein-loaded poly(D,L-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics. J. Control. Rel. 43:1997;89-102.
25. Bodmeier R., McGinity J.W. Solvent selection in the preparation of poly(D,L-lactide) microparticles prepared by the solvent evaporation method. Int. J. Pharm. 43:1988;179-186.
26. Pettit D.K., Lawter J.R., Huang W.J., Pankey S.C., Nightlinger N.S., Lynch D.H., Schuh J.A.C.L., Morrissey P.J., Gombotz W.R. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF. Pharm. Res. 14:(10):1997;1422-1430.
27. Nihant N., Schugens C., Grandfils C., Jérôme R., Teyssié P. Polylactide microparticles prepared by double emulsion/evaporation technique. I. Effect of primary emulsion stability. Pharm. Res. 11:(10):1994;1479-1484.
28. Pean J.M., Boury F., Venier-Julienne M.C., Menei P., Proust J.-E., Benoit J.P. Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres? Pharm. Res. 16:(8):1999;1294-1299.
29. Okubo T., Kobayashi K. Surface tension of biological polyelectrolytes solutions. J. Colloid. Interf. Sci. 205:1998;433-442.